Home › Companies › Arcturus Therapeutics Holdings Inc. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed June 6, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 6, 2025: 11 items on Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed June 6, 2025: 9 elected · 2 approved.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Arcturus Therapeutics Holdings Inc. in the interactive database Compare manager voting policies
These tallies are Arcturus Therapeutics Holdings Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Peter Farrell | 18,907,661 | -- | -- | 215,201 | 2,883,662 | 99% | Elected | — |
| Elect Director: Joseph E. Payne | 18,932,228 | -- | -- | 190,634 | 2,883,662 | 99.0% | Elected | — |
| Elect Director: Andy Sassine | 18,757,976 | -- | -- | 364,886 | 2,883,662 | 98% | Elected | — |
| Elect Director: James Barlow | 18,821,935 | -- | -- | 300,927 | 2,883,662 | 98% | Elected | — |
| Elect Director: Dr. Edward W. Holmes | 18,555,174 | -- | -- | 567,688 | 2,883,662 | 97% | Elected | — |
| Elect Director: Dr. Magda Marquet | 18,791,599 | -- | -- | 331,263 | 2,883,662 | 98% | Elected | — |
| Elect Director: Dr. Jing L. Marantz | 18,805,219 | -- | -- | 317,643 | 2,883,662 | 98% | Elected | — |
| Elect Director: Dr. John H. Markels | 18,969,935 | -- | -- | 152,927 | 2,883,662 | 99.2% | Elected | — |
| Elect Director: Dr. Moncef Slaoui | 19,059,965 | -- | -- | 62,897 | 2,883,662 | 99.7% | Elected | — |
| Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement | 18,472,131 | 586,006 | 64,724 | -- | 2,883,662 | 97% | Approved | — |
| Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2025, as provided in Proposal Number 3 of the Proxy Statement | 21,971,168 | 30,589 | 4,767 | -- | -- | 99.9% | Approved | — |
Source: Arcturus Therapeutics Holdings Inc., Form 8-K, filed with the SEC on June 6, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
176 asset managers disclosed a vote on at least one Arcturus Therapeutics Holdings Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 98.7% for (June 14, 2024 meeting) ▼ 0.6 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Andy Sassine
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Andy Sassine”): 18,757,976 for, 364,886 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,772,850 for, 29,880 withheld, 257 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 389,974 | 0 | 0 | 0 | For |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 63,114 | 0 | 0 | 0 | For |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,424 | 0 | 0 | 432 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 13,474 | Withhold |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 0 | 0 | 12,391 | Withhold |
| Columbia Threadneedle | 11,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 94.7% for (June 14, 2024 meeting) ▲ 2.3 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Edward W. Holmes”): 18,555,174 for, 567,688 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,667,200 for, 135,530 withheld, 257 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 389,974 | 0 | 0 | 0 | For |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 40,314 | 0 | 0 | 22,800 | Mixed |
| MFS | 0 | 0 | 0 | 60,129 | Withhold |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 16,716 | Withhold |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 13,474 | Withhold |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 11,775 | Withhold |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.1% for (June 14, 2024 meeting) ▲ 1.3 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Jing L. Marantz”): 18,805,219 for, 317,643 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,746,209 for, 56,335 withheld, 443 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 333,737 | 0 | 0 | 56,237 | Mixed |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 63,114 | 0 | 0 | 0 | For |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Prior year: 98.7% for (June 14, 2024 meeting) ▲ 0.5 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. John H. Markels”): 18,969,935 for, 152,927 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,780,187 for, 22,800 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 389,974 | 0 | 0 | 0 | For |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 40,314 | 0 | 0 | 22,800 | Mixed |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.2% for (June 14, 2024 meeting) ▲ 1.1 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Magda Marquet”): 18,791,599 for, 331,263 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,746,209 for, 56,335 withheld, 443 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 333,737 | 0 | 0 | 56,237 | Mixed |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 63,114 | 0 | 0 | 0 | For |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef Slaoui
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Moncef Slaoui”): 19,059,965 for, 62,897 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,802,987 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 389,974 | 0 | 0 | 0 | For |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 63,114 | 0 | 0 | 0 | For |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.2% for (June 14, 2024 meeting) ▼ 0.4 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Peter Farrell”): 18,907,661 for, 215,201 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,800,670 for, 2,317 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 389,974 | 0 | 0 | 0 | For |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 63,114 | 0 | 0 | 0 | For |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.4% for (June 14, 2024 meeting) ▲ 1.1 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: James Barlow”): 18,821,935 for, 300,927 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,723,409 for, 79,135 withheld, 443 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 333,737 | 0 | 0 | 56,237 | Mixed |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 40,314 | 0 | 0 | 22,800 | Mixed |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Prior year: 99.6% for (June 14, 2024 meeting) ▼ 0.6 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Joseph E. Payne”): 18,932,228 for, 190,634 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 10,802,987 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 389,974 | 0 | 0 | 0 | For |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 63,114 | 0 | 0 | 0 | For |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
97% Approved · of votes cast
Prior year: 94.9% for (June 14, 2024 meeting) ▲ 2.0 pts
Description as filed by funds: Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement”): 18,472,131 for, 586,006 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal was approved.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 333,737 | 56,237 | 0 | 0 | Mixed |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 63,114 | 0 | 0 | 0 | For |
| MFS | 0 | 60,129 | 0 | 0 | Against |
| State Street | 59,679 | 20 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 0 | 53,003 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 18,322 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
Fund voting reports, all 53 managers: 10,642,539 for, 178,770 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| Nikko Asset Management Co., Ltd. | 1,927,105 | 0 | 0 | 0 | For |
| BlackRock | 640,718 | 3,271 | 0 | 0 | For |
| State Street | 363,692 | 7,790 | 0 | 0 | For |
| Woodline Partners LP | 366,790 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 361,080 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 334,219 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 273,467 | 0 | 0 | 0 | For |
| JPMorgan | 224,067 | 0 | 0 | 0 | For |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Northern Trust | 130,512 | 117 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 115,059 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 94,419 | 0 | 0 | Against |
| STATE OF WISCONSIN INVESTMENT BOARD | 80,179 | 0 | 0 | 0 | For |
| Wellington | 67,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 62,437 | 0 | 0 | 0 | For |
| Vanguard | 60,868 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0 | 60,129 | 0 | 0 | Against |
| Fidelity | 0 | 57,455 | 0 | 0 | Against |
| Nuveen | 55,925 | 0 | 0 | 0 | For |
| American Century | 0 | 53,315 | 0 | 0 | Against |
| BALYASNY ASSET MANAGEMENT L.P. | 42,839 | 0 | 0 | 0 | For |
| Dimensional | 42,707 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 35,577 | 0 | 0 | 0 | For |
| Putnam | 34,370 | 0 | 0 | 0 | For |
Institutional-manager reports, all 141 managers: 10,437,184 for, 369,917 against. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Prior year: 99.9% for (June 14, 2024 meeting) unchanged
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2025, as provided in Proposal Number 3 of the Proxy Statement”): 21,971,168 for, 30,589 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2025, as provided in Proposal Number 3 of the Proxy Statement”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 10,821,309 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Federated Hermes | 4,694,060 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,970,673 | 0 | 0 | 0 | For |
| Vanguard | 1,704,567 | 0 | 0 | 0 | For |
| BlackRock | 1,021,530 | 0 | 0 | 0 | For |
| Fidelity | 389,974 | 0 | 0 | 0 | For |
| Charles Schwab | 195,909 | 0 | 0 | 0 | For |
| Dimensional | 137,095 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,714 | 0 | 0 | 0 | For |
| Equitable | 63,114 | 0 | 0 | 0 | For |
| MFS | 60,129 | 0 | 0 | 0 | For |
| State Street | 59,699 | 0 | 0 | 0 | For |
| TIAA | 54,792 | 0 | 0 | 0 | For |
| American Century | 53,003 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,170 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,767 | 0 | 0 | 0 | For |
| JPMorgan | 24,107 | 0 | 0 | 0 | For |
| Nationwide | 21,856 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 18,322 | 0 | 0 | 0 | For |
| Putnam | 17,771 | 0 | 0 | 0 | For |
| Northern Trust | 16,716 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 16,283 | 0 | 0 | 0 | For |
| ProShares | 14,602 | 0 | 0 | 0 | For |
| Global X | 13,474 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,414 | 0 | 0 | 0 | For |
| WisdomTree | 12,391 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 27,000,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Federated Hermes | 17.39% |
| 2 | ARK ETF Trust | 7.30% |
| 3 | Vanguard | 6.31% |
| 4 | BlackRock | 3.78% |
| 5 | Fidelity | 1.44% |
| 6 | Charles Schwab | 0.73% |
| 7 | Dimensional | 0.51% |
| 8 | Goldman Sachs | 0.28% |
| 9 | Equitable | 0.23% |
| 10 | MFS | 0.22% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Federated Hermes | 17.39% |
| 2 | Nikko Asset Management Co., Ltd. | 7.14% |
| 3 | BlackRock | 2.39% |
| 4 | State Street | 1.38% |
| 5 | Woodline Partners LP | 1.36% |
| 6 | JUPITER ASSET MANAGEMENT LTD | 1.34% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.24% |
| 8 | Vestal Point Capital, LP | 1.01% |
| 9 | JPMorgan | 0.83% |
| 10 | Charles Schwab | 0.73% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Federated Hermes, Inc. | 3,303,640 | 12.24% | Schedule 13G, filed January 8, 2026 |
| ARK Investment Management LLC | 2,947,556 | 10.92% | Schedule 13G, filed May 7, 2026 |
| BlackRock | 2,759,970 | 10.22% | Form 13F, quarter ended March 31, 2025 |
| Amova Asset Management Americas, Inc. | 1,947,835 | 7.21% | Schedule 13G, filed November 13, 2025 |
| Vanguard Group | 1,748,928 | 6.48% | Form 13F, quarter ended March 31, 2025 |
| State Street | 1,280,451 | 4.74% | Form 13F, quarter ended March 31, 2025 |
| Dimensional Fund Advisors | 616,634 | 2.28% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 569,620 | 2.11% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 551,726 | 2.04% | Form 13F, quarter ended March 31, 2025 |
| Goldman Sachs | 509,712 | 1.89% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 27,000,000 shares outstanding, as reported by Arcturus Therapeutics Holdings Inc. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Arcturus Therapeutics Holdings Inc.'s shareholder meeting held June 6, 2025, in the 2024-2025 proxy season, 176 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 2,033 separate fund positions. On the most widely held item on that ballot — Approval, by non-binding advisory vote, of the resolution approving the Company's Named… — Arcturus Therapeutics Holdings Inc.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Arcturus Therapeutics Holdings Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Arcturus Therapeutics Holdings Inc.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Arcturus Therapeutics Holdings Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “Arcturus Therapeutics Holdings (ARCT) 2025 Annual Meeting”, https://proxyvotesnow.com/company/arcturus-therapeutics-holdings-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.